Matches in Nanopublications for { ?s ?p "DDI between Nortriptyline and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if atazanavir if initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB01072]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00540_DB01072 label "DDI between Nortriptyline and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if atazanavir if initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB01072]" assertion.